Royalty Pharma Beats Q1 Earnings and Revenue Estimates
Royalty Pharma (NASDAQ: RPRX) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $1.60 per share a year ago. These figures are adjusted for non-recurring items.
Emerson Electric (EMR) has been upgraded to Buy from Hold by Deutsche Bank, with a raised price target of $138 per share.
Uber's share price fell around 7% pre-market after announcing its first-quarter earnings.
Looking ahead, revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 5.3% growth forecast ...
Reddit’s first quarter as a public company was a strong one, with key metrics like its daily user count and average revenue ...
Walt Disney's streaming entertainment unit posted its first profit on Tuesday, two quarters ahead of schedule, and the media ...
Key Takeaways Ridesharing company Uber reports earnings before markets open Wednesday.Investors will likely be watching ...
CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of 12.27% and 93.94%, respectively, for the quarter ended ...
Fully diluted EPS reflects potential share dilution, offering a clearer financial picture. Earnings per share, or EPS, is a common financial metric used to gauge a company's profitability.
AMC stock is down over 90% in the last year. The company reports Q1 results on Wednesday, which could show a weak box office.
Sturm, Ruger & Company, Inc. (NYSE-RGR) announced today that for the first quarter of 2024, net sales were $136.8 million and diluted earnings wer ...
Shares of the two ride-hailing giants were moving in opposite directions Wednesday morning. Uber stock fell more than 6% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback